News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Zold - Clinical - PDUFA (World)
FDA Assigns PDUFA Date for Shire plc's FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema 3/21/2011
GlaxoSmithKline (GSK), Valeant Pharmaceuticals International (VRX) Face US Delay for Epilepsy Drug, Receives New PDUFA Date 8/31/2010
Warner Chilcott, PLC (WCRX) Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product 7/16/2010
GlaxoSmithKline (GSK) (JOBS) and XenoPort, Inc. (XNPT) Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 11/10/2009
Review of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Febuxostat New Drug Application Continues Past PDUFA Date 1/20/2009
Ipsen: FDA’s First-Cycle Review of Reloxin(R) Extended 1/7/2009
FDA Will Not Be Able To Complete Its Review Of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s (JOBS) Alogliptin (SYR-322) NDA By The Prescription Drug User Fee Act (PDUFA) Date Of October 27, 2008; Delay Puts PPD, Inc. (PPDI) Payment On Hold 10/10/2008
Ipsen: FDA's First-Cycle Review of Dysport(R) to Be Completed by Year-End 9/30/2008